Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
58
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Multi Cytogenetic Changes in a Patient as Co-Existing MDS and CLL Progresses

Xiangxin LiDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Jiale MaDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Luqun WangDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Shuxin YanDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Fanglin LiDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Lingling WangDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Lin WangDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Guosheng LiDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
,
Daoxin MaDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaView further author information
&
Hao LiDepartment of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 177-186 | Published online: 08 Jan 2021

References

  • Fabbri G, Dalla-Favera R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer. 2016;16:145–162. doi:10.1038/nrc.2016.8
  • Cramer P, Isfort S, Bahlo J, et al. Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG). Haematologica. 2015;100:1451–1459. doi:10.3324/haematol.2015.124693
  • Bracey AW, Maddox AM, Immken L, Hsu SM, Marks ME. Coexistence of myelodysplastic syndrome and untreated chronic lymphocytic leukemia with development of acute myeloid leukemia immediately after treatment of chronic lymphocytic leukemia. Am J Hematol. 1989;30(3):174–180. doi:10.1002/ajh.2830300310
  • Sylvester LS, Nowell PC, Bonner H, Moreau L, Moore JS. Concurrent diagnosis of chronic lymphocytic leukemia and myelodysplastic syndrome. Leuk Res. 1997;21(7):619–621. doi:10.1016/s0145-2126(97)00017-9
  • Lai R, Arber DA, Brynes RK, Chan O, Chang KL. Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome - a report of five cases and review of the literature. Am J Clin Pathol. 1999;111(3):373–378. doi:10.1093/ajcp/111.3.373
  • Hana A, Denga T, Kasturi D, et al. Simultaneous appearance of trisomy 8 and trisomy12 in different cell populations in a patient with untreated B-cell chronic lymphocytic leukemia and myelodysplasia. Leuk Lymphoma. 2004;45(6):1279–1283. doi:10.1080/10428190310001638869
  • Luca L, Michela T, Ilaria N, et al. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol. 2011;86(12):1007–1012. doi:10.1002/ajh.22171
  • Tambaro FP, Garcia-Manero G, O’Brien SM, et al. Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome. Leukemia. 2016;30(2):325–330. doi:10.1038/leu.2015.227
  • Cameron Y, Guilin T, Gary L, et al. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Mod Pathol. 2015;28(8):1130–1137. doi:10.1038/modpathol.2015.58
  • Daniel AA, Attilio O, Robert H, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544
  • International CLL-IPI working group. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 2016;17:779–790. doi:10.1016/S1470-2045(16)30029-8
  • Cavallari M, Cavazzini F, Bardi A, et al. Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia. Oncotarget. 2018;9(76):34398–34412. doi:10.18632/oncotarget.26146
  • Kruzova L, Schneiderova P, Holzerova M, et al. Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: a single center experience over 12 years. Leuk Res. 2019;85:106218. doi:10.1016/j.leukres.2019.106218
  • Khaliqur R, Manish KS, Ruchi G, Sarjana D, Soniya N. De novo Philadelphia chromosome positive myelodysplastic syndrome: report of two cases with brief literature review. J Can Res Ther. 2020;16:173–176. doi:10.4103/0973-1482.188428
  • Yun S, Vincelette ND, Abraham I, et al. Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials. Clin Epigenetics. 2016;8(1). doi:10.1186/s13148-016-0233-2
  • Makishima H, Yoshida K, Nguyen N, et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet. 2013;45:942–946. doi:10.1007/s12185-017-2241-1
  • Kyoko I, Joun L, Stephanie C, et al. Non-catalytic roles of Tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis. Cell Rep. 2019;28:2480–2490. doi:10.1016/j.celrep.2019.07.094
  • María HS, Ana ER, Alexander K, et al. TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations. Biomed Res Int. 2014;2014:814294. doi:10.1155/2014/814294
  • Michaël VD, Emerence CN, Meuleman MM, et al. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance. Clin Epigenetics. 2016;8:132. doi:10.1186/s13148-016-0298-y

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.